The latest VAERS data revealed 262,521 reports of adverse events following COVID vaccines, including 4,406 deaths and 21,537 serious injuries between Dec. 14, 2020 and May 21, 2021.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. The CDC uses it for their data.
Friday’s data indicate between Dec. 14, 2020 and May 21, showed an increase of 205 deaths over the previous week — and 21,537 serious injuries, up 3,009 since last week.
Last week’s data showed 3,449 total adverse events, compared with 943 reports last week, among 12- to 17-year-olds. Last week’s data included 58 reports of serious adverse events in the 12- to -17-year-old age group.
In the U.S 281.6 million COVID vaccine doses had been administered as of May 21. This includes 120 million doses of Moderna’s vaccine, 152 million doses of Pfizer and 10 million doses of the Johnson & Johnson (J&J) COVID vaccine.
Of the 4,406 deaths reported as of May 21, 23% occurred within 48 hours of vaccination, 16% occurred within 24 hours and 38% occurred in people who became ill within 48 hours of being vaccinated.
Last week’s VAERS data show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 44% were female and the remaining death reports did not include gender of the deceased.
- The average age of death was 74.4 and the youngest deaths reported include two 15-year-olds (VAERS I.D. 1187918 and 1242573 ) and a 16-year-old (VAERS I.D. 1225942). There were other reported deaths in children under 16 that could not be confirmed or contained obvious errors.
- As of May 21, 1,641 pregnant women reported adverse events related to COVID vaccines, including 527 reports of miscarriage or premature birth.
- Of the 2,577 cases of Bell’s Palsy reported, 52% were reported after Pfizer-BioNTech vaccinations, 41% following vaccination with the Moderna vaccine and 192 cases, or 9%, of Bell’s Palsy cases were reported in conjunction with J&J.
- There were 238 reports of Guillain-Barré Syndrome with 43% of cases attributed to Pfizer, 38% to Moderna and 23% to J&J.
- There were 74,781 reports of anaphylaxis with 39% of cases attributed to Pfizer’s vaccine, 50% to Moderna and 10% to J&J.
- There were 4,433 reports of blood clotting disorders. Of those, 1,842 reports were attributed to Pfizer, 1,359 reports to Moderna and 1,194 reports to J&J.